These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 34767342)
21. Tumor microenvironment responsive nanogels as a smart triggered release platform for enhanced intracellular delivery of doxorubicin. Kumar P; Behl G; Kaur S; Yadav N; Liu B; Chhikara A J Biomater Sci Polym Ed; 2021 Feb; 32(3):385-404. PubMed ID: 33054642 [TBL] [Abstract][Full Text] [Related]
22. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery. Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976 [TBL] [Abstract][Full Text] [Related]
23. pH-Sensitive nanogels for drug delivery in cancer therapy. Li Z; Huang J; Wu J Biomater Sci; 2021 Feb; 9(3):574-589. PubMed ID: 33306076 [TBL] [Abstract][Full Text] [Related]
24. Multi-stimuli responsive nanogel/hydrogel nanocomposites based on κ-carrageenan for prolonged release of levodopa as model drug. Bardajee GR; Khamooshi N; Nasri S; Vancaeyzeele C Int J Biol Macromol; 2020 Jun; 153():180-189. PubMed ID: 32135252 [TBL] [Abstract][Full Text] [Related]
25. Bioengineered nanogels for cancer immunotherapy. Ma X; Li SJ; Liu Y; Zhang T; Xue P; Kang Y; Sun ZJ; Xu Z Chem Soc Rev; 2022 Jun; 51(12):5136-5174. PubMed ID: 35666131 [TBL] [Abstract][Full Text] [Related]
26. Bio-Orthogonal Nanogels for Multiresponsive Release. Alkanawati MS; Machtakova M; Landfester K; Thérien-Aubin H Biomacromolecules; 2021 Jul; 22(7):2976-2984. PubMed ID: 34129319 [TBL] [Abstract][Full Text] [Related]
28. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062 [TBL] [Abstract][Full Text] [Related]
29. Design and applications of polymer-like peptides in biomedical nanogels. Neamtu I; Ghilan A; Rusu AG; Nita LE; Chiriac VM; Chiriac AP Expert Opin Drug Deliv; 2024 May; 21(5):713-734. PubMed ID: 38916156 [TBL] [Abstract][Full Text] [Related]
30. Preparation and use of nanogels as carriers of drugs. Li C; Obireddy SR; Lai WF Drug Deliv; 2021 Dec; 28(1):1594-1602. PubMed ID: 34308729 [TBL] [Abstract][Full Text] [Related]
31. Responsive polymer-fluorescent carbon nanoparticle hybrid nanogels for optical temperature sensing, near-infrared light-responsive drug release, and tumor cell imaging. Wang H; Ke F; Mararenko A; Wei Z; Banerjee P; Zhou S Nanoscale; 2014 Jul; 6(13):7443-52. PubMed ID: 24881520 [TBL] [Abstract][Full Text] [Related]
32. Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. Maya S; Sarmento B; Nair A; Rejinold NS; Nair SV; Jayakumar R Curr Pharm Des; 2013; 19(41):7203-18. PubMed ID: 23489200 [TBL] [Abstract][Full Text] [Related]
33. Polyethyleneimine modified biocompatible poly(N-isopropylacrylamide)-based nanogels for drug delivery. Quan CY; Wei H; Sun YX; Cheng SX; Shen K; Gu ZW; Zhang XZ; Zhuo RX J Nanosci Nanotechnol; 2008 May; 8(5):2377-84. PubMed ID: 18572652 [TBL] [Abstract][Full Text] [Related]
34. New progress and prospects: The application of nanogel in drug delivery. Zhang H; Zhai Y; Wang J; Zhai G Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():560-568. PubMed ID: 26706564 [TBL] [Abstract][Full Text] [Related]
35. Advances in intelligent-responsive nanocarriers for cancer therapy. Tian M; Xin X; Wu R; Guan W; Zhou W Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111 [TBL] [Abstract][Full Text] [Related]
36. Self-Assembled Hybrid Nanogel as a Multifunctional Theranostic Probe for Enzyme-Regulated Ultrasound Imaging and Tumor Therapy. Wu Q; Zhang Q; Yu T; Wang X; Jia C; Zhao Z; Zhao J ACS Appl Bio Mater; 2021 May; 4(5):4244-4253. PubMed ID: 35006837 [TBL] [Abstract][Full Text] [Related]
37. "Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications". Shah S; Rangaraj N; Laxmikeshav K; Sampathi S Int J Pharm; 2020 May; 581():119268. PubMed ID: 32240803 [TBL] [Abstract][Full Text] [Related]
38. Bioresponsive functional nanogels as an emerging platform for cancer therapy. Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103 [TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-loaded composite nanogels for cancer treatment. Mohammadi M; Arabi L; Alibolandi M J Control Release; 2020 Dec; 328():171-191. PubMed ID: 32866591 [TBL] [Abstract][Full Text] [Related]
40. Stimuli-responsive drug delivery systems for head and neck cancer therapy. Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]